These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27798957)

  • 1. Identification of an IgG CDR sequence contributing to co-purification of the host cell protease cathepsin D.
    Bee JS; Machiesky LM; Peng L; Jusino KC; Dickson M; Gill J; Johnson D; Lin HY; Miller K; Heidbrink Thompson J; Remmele RL
    Biotechnol Prog; 2017 Jan; 33(1):140-145. PubMed ID: 27798957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
    Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
    Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a cathepsin D protease from CHO cell-free medium and mitigation of its impact on the stability of a recombinant therapeutic protein.
    Lim A; Doyle BL; Kelly GM; Reed-Bogan AM; Breen LH; Shamlou PA; Lambooy PK
    Biotechnol Prog; 2018 Jan; 34(1):120-129. PubMed ID: 28726323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
    Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
    Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D: Removal strategy on protein A chromatography, near real time monitoring and characterisation during monoclonal antibody production.
    Cui T; Chi B; Heidbrink Thompson J; Kasali T; Sellick C; Turner R
    J Biotechnol; 2019 Nov; 305():51-60. PubMed ID: 31442501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the co-elution of host cell proteins with monoclonal antibodies during protein A purification.
    Zhang Q; Goetze AM; Cui H; Wylie J; Tillotson B; Hewig A; Hall MP; Flynn GC
    Biotechnol Prog; 2016 May; 32(3):708-17. PubMed ID: 27073178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hydrolysates on monoclonal antibody productivity, purification and quality in Chinese hamster ovary cells.
    Ho SC; Nian R; Woen S; Chng J; Zhang P; Yang Y
    J Biosci Bioeng; 2016 Oct; 122(4):499-506. PubMed ID: 27067279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of cathepsin D-mAb interactions using a combined experimental and computational tool set.
    Ranjan S; Chung WK; Hofele R; Heidbrink Thompson J; Bee J; Zhang L; Robbins D; Cramer SM
    Biotechnol Bioeng; 2019 Jul; 116(7):1684-1697. PubMed ID: 30882893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of hexamer peptide ligands for affinity purification of immunoglobulin G from commercial cell culture media.
    Naik AD; Menegatti S; Gurgel PV; Carbonell RG
    J Chromatogr A; 2011 Apr; 1218(13):1691-700. PubMed ID: 21176908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
    Goey CH; Bell D; Kontoravdi C
    MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms.
    Hecht ES; Mehta S; Wecksler AT; Aguilar B; Swanson N; Phung W; Dubey Kelsoe A; Benner WH; Tesar D; Kelley RF; Sandoval W; Sreedhara A
    MAbs; 2022; 14(1):2135183. PubMed ID: 36284469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification process of recombinant monoclonal antibodies with mixed mode chromatography.
    Maria S; Joucla G; Garbay B; Dieryck W; Lomenech AM; Santarelli X; Cabanne C
    J Chromatogr A; 2015 May; 1393():57-64. PubMed ID: 25805720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification.
    Borlido L; Moura L; Azevedo AM; Roque AC; Aires-Barros MR; Farinha JP
    Biotechnol J; 2013 Jun; 8(6):709-17. PubMed ID: 23420794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
    Levy NE; Valente KN; Lee KH; Lenhoff AM
    Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
    Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
    Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
    Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
    MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of an Fc-fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D protease.
    Robert F; Bierau H; Rossi M; Agugiaro D; Soranzo T; Broly H; Mitchell-Logean C
    Biotechnol Bioeng; 2009 Dec; 104(6):1132-41. PubMed ID: 19655395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies.
    Thomson AS; Mai S; Byrne MP
    Biotechnol Bioeng; 2017 Jun; 114(6):1208-1214. PubMed ID: 28112396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide ligands for antibody purification provide superior clearance of host cell protein impurities.
    Reese HR; Xiao X; Shanahan CC; Chu W; Van Den Driessche GA; Fourches D; Carbonell RG; Hall CK; Menegatti S
    J Chromatogr A; 2020 Aug; 1625():461237. PubMed ID: 32709313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.